Show simple item record

dc.creatorAbrishami, Mahsa
dc.date.accessioned2019-01-11T17:10:03Z
dc.date.created2018-10
dc.date.issued2019-01-11
dc.date.submittedOctober 2018
dc.identifier.urihttp://hdl.handle.net/10388/11711
dc.description.abstract

This thesis is under an embargo.

Access to the abstract and all associated documents will not be permitted until 2021-01-11.

dc.format.mimetypeapplication/pdf
dc.subjectSynthetic antibodies, IL-3, CML, Chronic myeloid leukemia, Imatinib, Innate Drug Resistance, Therapeutics
dc.titleGENERATION OF SYNTHETIC ANTIBODIES AS POTENTIAL THERAPEUTICS TO BLOCK IL3–MEDIATED INNATE IMATINIB RESISTANCE IN CHRONIC MEYLOID LEUKEMIA
dc.typeThesis
dc.date.updated2019-01-11T17:10:04Z
thesis.degree.departmentPathology and Laboratory Medicine
thesis.degree.disciplineHealth Sciences
thesis.degree.grantorUniversity of Saskatchewan
thesis.degree.levelDoctoral
thesis.degree.nameDoctor of Philosophy (Ph.D.)
dc.type.materialtext
dc.contributor.committeeMemberDeCoteau, John F
dc.contributor.committeeMemberVizeacoumar, Franco
dc.contributor.committeeMemberUppalapati, Maruti
dc.contributor.committeeMemberFreywald, Andrew
local.embargo.lift2021-01-11
local.embargo.terms2021-01-11


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record